Mindfulness-Based Intervention for Depression

Recruiting in Palo Alto (17 mi)

Overseen byChelsea Siwik, PhD

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Case Comprehensive Cancer Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to develop and test a new intervention to reduce depressive symptoms in post-treatment cancer participants.

Research Team

Chelsea Siwik, PhD

Principal Investigator

Case Comprehensive Cancer Center, Cleveland Clinic

Eligibility Criteria

This trial is for individuals who have completed treatment for breast, prostate, or colorectal cancer and are experiencing depressive symptoms. Participants should be interested in a mindfulness-based intervention sent via text messages.

Inclusion Criteria

Ability to read and speak English

Access to a web-enabled device (phone, tablet, computer)

Ability to provide informed consent

See 3 more

Exclusion Criteria

Self-reported active mindfulness practice

Self-reported suicidal ideation (>1 on item 9 PHQ-9)

Presence of another psychological, medical, or other condition/issue determined to necessitate priority treatment and/or interfere with participation (e.g., schizophrenia, borderline personality disorder)

See 5 more

Treatment Details

Interventions

MINDSET (Behavioral Intervention)

Trial OverviewThe study is testing 'MINDSET', a new text message-based mindfulness program designed to alleviate depression in post-treatment cancer patients, compared with Enhanced Usual Care (EUC), which represents the standard support provided.

Participant Groups

2Treatment groups

Experimental Treatment

Group I: ARM 2Experimental Treatment1 Intervention

Participants will be randomized to EUC

Group II: ARM 1Experimental Treatment1 Intervention

Participants will be randomized to MINDSET